Data published in JAMA Network Open suggest that prescribing practices of antiretroviral therapy (ART) in pregnant women living with HIV in the United States do not align optimally with national guidelines. In this prospective cohort study including data from 1867 pregnancies in 1582 women living with HIV, 49.5% were associated with prescribed ART designated as…
Safety and efficacy of isoniazid for the prevention of tuberculosis may vary between HIV-infected pregnant and postpartum women.
Maternal efavirenz use tied to increased risk among children who are HIV-exposed but uninfected
Front-line providers minimally could check HBV DNA and ALT during pregnancy to assess mother‐to‐child transmission risk but HBeAg is recommended to be included in the initial HBV evaluation to get a more comprehensive understanding of the patient’s HBV disease state.
Maternal viremia predicted fetal infection and neonatal outcome of infants of women with a primary cytomegalovirus infection during pregnancy.
The rate of hepatitis C virus infection (HCV) in pregnant women at the time of delivery in the US increased from 0.8 per 1000 live births in 2000 to 4.1 per 1000 in 2015.
USPSTF recommends against screening for bacterial vaginosis in pregnant women who are not at increased risk for preterm delivery.
Many pregnant women do not receive the recommended flu and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines to protect themselves and their infants.
Among women giving birth, the rates of HCV infection increased more than 400% from 2000 to 2015, with rates much higher among those with opioid use disorder.
No net benefit seen for screening, treatment of asymptomatic bacteriuria for nonpregnant adults
